Silencing of HPV 18 oncoproteins with RNA interference causes growth inhibition of cervical cancer cells

Reproductive Sciences

Volumn 14, Issue 1, 2007, Pages 20-28

  Lea, Jayanthi S ^a   Sunaga, Noriaki ^b   Sato, Mitsuo ^b   Kalahasti, Geetha ^b   Miller, David S ^b   Minna, John D ^b   Muller, Carolyn Y ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

Cervical cancer; HPV; RNA interference; Targeted therapy

Indexed keywords

MESSENGER RNA; PROTEIN E6; PROTEIN E7; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; TAX PROTEIN; DNA BINDING PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; E7 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; ONCOPROTEIN; PRIMER DNA; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; UTERINE CERVIX CANCER; WESTERN BLOTTING; CELL CYCLE; CELL DIVISION; CLONOGENIC ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; KINETICS; LUNG TUMOR; UTERINE CERVIX TUMOR; VIROLOGY;

CELL CYCLE; CELL DIVISION; COLONY-FORMING UNITS ASSAY; DNA PRIMERS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HUMAN PAPILLOMAVIRUS 18; HUMANS; KINETICS; LUNG NEOPLASMS; ONCOGENE PROTEINS, VIRAL; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA, VIRAL; TRANSFECTION; UTERINE CERVICAL NEOPLASMS; VIRAL PROTEINS;

EID: 34648837230     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719106298189     Document Type: Article

References (27)

1. Chakrabarti O, Krishna S. Molecular interactions of high risk human papillomaviruses E6 and E7 oncoproteins: implications for tumor progression. J Biosci. 2003 ; 28: 337-348.
2. Pim D, Massimi P, Banks L. Alternatively spliced HPV 18 E6*protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth. Oncogene. 1997 ; 15: 257-264.
3. Zur Hausen H. Papillomaviruses causing cancer: evasion from host cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000 ; 92: 690-698.
4. Khan MJ, Castle PE, Lorinz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005 ; 97: 1072-1079.
5. Corden SA, Sant-Cassia LJ, Easton AJ, Morris AG. The integration of HPV-18 DNA in cervical carcinoma. Mol Pathol. 1999 ; 52: 275-282.
6. Thomas M, Pim D, Banks L. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene. 1999 ; 18: 7690-7700.
7. Bedell MA, Jones KH, Laimens LA. The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3t3 and rat cells. J Virol. 1987 ; 61: 3401-3440.
8. Herber R, Liem A, Pitot H, Lambert PF. Squamous and epithelial hyperplasia in mice transgenic for the human papillomavirus type 16 E7 oncogene. J Virol. 1996 ; 70: 1873-1881.
9. Vousden K. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes. FASEB J. 1993 ; 7: 872-879.
10. Alvarez-Salas LM, Cullinan AE, Siwkowski A, Hampel A, Dipaolo JA. Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes. Proc Natl Acad Sci U S A. 1998 ; 95: 1189-1194.
11. Choo CK, Ling MT, Suen CKM, Chan KW, Kwong YL. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells. Gynecol Oncol. 2000 ; 78: 293-301.
12. Venturini F, Braspenning J, Homann M, Gismann L, Sczakiel G. Kinetic selection of HPV 16 E6/E7 directed antisense nucleic acids: antiproliferative effect on HPV 16 transformed cells. Nucleic Acids Res. 1999: 27: 1585-1592.
13. Scherer LJ, Rossi JJ. Approaches for the sequence-specific knockdown of mRNA. Nat Biotechnol. 2003 ; 21: 1457-1465.
14. Sharp P. RNA interference - 2001. Genes Dev. 2001 ; 15: 485-490.
15. Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods. 2002 ; 26: 199-213.
16. Chi J-T, Chang HY, Wang NN, Chang DS, Dunphy N, Brown PO. Genomewide view of gene silencing by small interfering RNAs. Proc Natl Acad Sci. 2003 ; 100: 6343-6346.
17. Jiang M, Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene. 2002 ; 21: 6041-6048.
18. Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene. 2003 ; 22: 5938-5945.
19. Hall AHS, Alexander KA. RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol. 2003 ; 77: 6066-6069.
20. Sunaga N, Miyajima K, Suzuki M. Different roles for Caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Cancer Res. 2004 ; 64: 4277-4285.
21. Jackson AL, Bartz SR, Schelter J, et al. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol. 2003 ; 21: 635-638.
22. DeFilippis RA, Goodwin EC, Wu L, DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence and apoptosis in cervical carcinoma cells. J Virol. 2003 ; 77: 1551-1563.
23. Kastan MB, Onyekwere O, Sidrasky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991 ; 51: 6304-6311.
24. Jones DL, Munger K. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J Virol. 1997 ; 71: 2905-2912.
25. Munger K, Basile JR, Duensing S, et al. Biological activities and molecular targets of the human papillomavirus E7 onco-protein. Oncogene. 2001 ; 20: 7888-7898.
26. Bischof O, Nacerddine K, Dejean A. Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways. Mol Cell Biol. 2005 ; 25: 1013-1024.
27. Mantovani F, Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene. 2001 ; 20: 7874-7887.